NCT06503016View on ClinicalTrials.gov

The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
HypotensionConsciousness, Level AlteredAirway DiseaseRespiratory FailureTachypneaBradypneaTachycardiaBradycardiaCardiac FailureCardiac Arrest
Interventions
DRUG

Phosphocreatine

Administration of Phosphocreatine

DRUG

Placebo

Saline solution of NaCl 0.9%

Trial Locations (1)

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors
collaborator

Silvia Ajello

UNKNOWN

lead

Università Vita-Salute San Raffaele

OTHER